Cost and Prevalence of Metastatic Breast Cancer Expected to Rise Through 2030

“The results of this study highlight groups of [patients with metastatic breast cancer] by age that may require support to mitigate the adverse economic consequences from medical and productivity costs associated with the disease,” the investigators wrote.

from Google Alert - Business https://ift.tt/3wyJTOR
“The results of this study highlight groups of [patients with metastatic breast cancer] by age that may require support to mitigate the adverse economic consequences from medical and productivity costs associated with the disease,” the investigators wrote. https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Jobless Rate Drops

Electrolytic Fixed Power Capacitors Market Competitive intelligence & regional outlook 2020

USU project among finalists for $3 million solar energy tech prize